These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30884095)
21. The current landscape of nucleic acid therapeutics. Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811 [TBL] [Abstract][Full Text] [Related]
22. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid. Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806 [TBL] [Abstract][Full Text] [Related]
23. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
24. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy. Avci-Adali M; A Santos H Adv Drug Deliv Rev; 2022 Jun; 185():114297. PubMed ID: 35427721 [No Abstract] [Full Text] [Related]
26. Formulating the magic bullet: barriers to clinical translation of nanoparticle cancer gene therapy. Hendricks WP; Yang J; Sur S; Zhou S Nanomedicine (Lond); 2014; 9(8):1121-4. PubMed ID: 25118704 [No Abstract] [Full Text] [Related]
27. Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes. Ewert KK; Kotamraju VR; Majzoub RN; Steffes VM; Wonder EA; Teesalu T; Ruoslahti E; Safinya CR Bioorg Med Chem Lett; 2016 Mar; 26(6):1618-1623. PubMed ID: 26874401 [TBL] [Abstract][Full Text] [Related]
28. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bartlett DW; Davis ME Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672 [TBL] [Abstract][Full Text] [Related]
29. Self-assembly of stable monomolecular nucleic acid lipid particles with a size of 30 nm. Rudorf S; Rädler JO J Am Chem Soc; 2012 Jul; 134(28):11652-8. PubMed ID: 22694262 [TBL] [Abstract][Full Text] [Related]
30. Lipid-based nanoparticles for nucleic acid delivery. Li W; Szoka FC Pharm Res; 2007 Mar; 24(3):438-49. PubMed ID: 17252188 [TBL] [Abstract][Full Text] [Related]
31. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
33. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles. Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406 [TBL] [Abstract][Full Text] [Related]